Three more health apps obtained reimbursement in Germany

27

Oct 2022

In late September – early October 2022, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by sickness funds.

The health app “re.flex” was introduced in the DiGA Directory on September 29, 2022. “re.flex”, developed by Kineto Tech Rehab SRL, Romania, provides patients with gonarthrosis with guided and controlled sports and exercise therapy. This consists of an app and two motion sensors. A detailed and indication-specific training program allows the patients to train independently and document the training activity. The exercise program was developed jointly by Sporlastic Medical Products GmbH and the sports medicine department of the University Hospital in Tübingen and is based on the current state of science and current study-based guidelines. The app with the movement sensors is available in German and English with a tariff of €784.21.

On October 10, 2022, two more health apps were introduced in the Directory. “Endo-App”, developed by Endo Health GmbH, Germany, is a health app for multimodal support for people affected by endometriosis. The program aims to support users in improving their quality of life as part of self-management. The self-management concept is fundamentally based on a symptom diary, in which users can document their symptoms, activities, exercises, and treatment, as well as on multimodal content. As part of the multimodal therapy, knowledge-transferring elements, validated questionnaires, guided exercises, and techniques from gynecology, physiotherapy, psychology, pain therapy, rehabilitation, social pedagogy, nutrition, resource activation, and resilience strengthening are available. The app is available in German with a tariff of €598.95.

The health app “sinCephalea – Migräneprophylaxe”, developed by Perfood GmbH, Germany, supports guideline-based prevention of migraine attacks. Based on individual blood sugar reactions to food and meals, “sinCephalea” creates personalized recommendations for a low-glycemic diet, which are made available in the app in the form of a nutrition report. “sinCephalea” also includes a headache diary and regular migraine questionnaires, which can be used to record headaches and migraine symptoms as well as the impairment in everyday life. The app is available in German with a tariff of €690.

The full details in German can be found here (re.flex), here (Endo-App), and here (sinCephalea – Migräneprophylaxe).

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

27

Jan 2023

On January 09, 2023, the National Institute for Health and Disability Insurance (INAMI-RIZIV) published 2023 tariffs for the “low variability care” (APR-DRG) system. APR-DRG logic for 2023 is not published as of January 27, so no information about its changes or new DRGs is available.

Read more

26

Jan 2023

The updated German Uniform Evaluation Standard (EBM) catalog came into force on January 1, 2023. The EBM catalog (Einheitlicher Bewertungsmaßstab) regulates the reimbursement of services in the public outpatient sector in Germany and is updated once a quarter (four times a year). Among other changes, a new code for "zanadio" health app for follow-up and evaluation was introduced in the catalog.

Read more

25

Jan 2023

On December 31, 2022, the Decree defining the reimbursement of medical telemonitoring activities via the new framework was published in the Official Journal of the French Republic. The Decree determines the methods of evaluation of digital solutions, registration for reimbursement, modification of the registration conditions, removal and invoicing of medical telemonitoring activities, as well as the conditions for setting the reimbursement packages.

Read more

24

Jan 2023

In December 2022, NHS England launched a consultation on the preliminary 2023/25 NHS Payment Scheme, which is set for two years and will replace the National Tariff Payment System from April 2023. Two new cardiovascular categories (antibacterial envelope, mitral valve repair and replacement devices) are proposed for inclusion in the 2023/24 High Cost Device List (will be updated and reissued for 2024/25). The deadline for comments submission is January 27, 2023.

Read more

23

Jan 2023

On December 26, 2022, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by sickness funds.

Read more